Regulation and role of adenylyl cyclase isoforms

Annual Review of Pharmacology and Toxicology

Volumn 41, Issue , 2001, Pages 145-174

  Hanoune, J ^a   Defer, N ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

Cell physiology; Mammals; Signal transduction

Indexed keywords

ADENYLATE CYCLASE; CALCIUM; CALMODULIN; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN;

ALCOHOLISM; CALCIUM TRANSPORT; DRUG DEPENDENCE; ENZYME MECHANISM; ENZYME REGULATION; ENZYME STRUCTURE; ENZYME SUBUNIT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SPERMATOZOON MATURATION; TISSUE DISTRIBUTION; TISSUE SPECIFICITY;

ADENYLATE CYCLASE; ANIMALS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; ISOENZYMES;

MAMMALIA;

EID: 0035040818     PISSN: 03621642     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.pharmtox.41.1.145     Document Type: Review

References (213)

1. The catalytic mechanism of mammalian adenylyl adenylyl cyclase: Equilibrium binding and kinetic analysis of P-site inhibition
2. The adenylyl and guanylyl cyclase superfamily
3. The structure, catalytic mechanism and regulation of adenylyl cyclase
4. G protein regulation of adenylate cyclase
5. Structure, mechanism, and regulation of mammalian adenylyl cyclase
6. Tissue specificity and physiological relevance of the various isoforms of adenylyl cyclase
7. Ca(2+)-sensitive adenylyl cyclases
8. 2+ sensitive adenylyl cyclase activity is disrupted in the brains of type I adenylyl cyclase mutant mice
9. Type I adenylyl cyclase mutant mice have impaired mossy fiber long-term potentiation
10. Altered behavior and long-term potentiation in type I adenylyl cyclase mutant mice
11. Localization of adenylyl and guanylyl cyclase in rat brain by in situ hybridization: Comparison with calmodulin mRNA distribution
12. 2+-insensitive adenylyl cyclases in the rat brain
13. Distribution of type II adenylyl cyclase mRNA in the rat brain
14. Selective expression of one Ca(2+)-inhibitable adenylyl cyclase in dopaminergically innervated rat brain regions
15. Immunohistochemical localization of adenylyl cyclase in rat brain indicates a highly selective concentration in synapses
16. Localization of the gene for a novel human adenylyl cyclase (ADCY7) to chromosome 16
17. CREB (cAMP response element-binding protein) in the locus coeruleus: Biochemical, physiological, and behavioral evidence for a role in opiate dependence
18. 2+/calcineurin-inhibited adenylyl cyclase, highly abundant in forebrain regions, is important for learning and memory
19. Distribution of mRNA for the calmodulin-sensitive adenylate cyclase in rat brain: Expression in areas associated with learning and memory
20. 2+ sensitivity
21. Multiple effect of the activity of adenylyl cyclase from the Drosophila memory mutant rutabaga
22. Loss of calcium/calmodulin responsiveness in adenylate cyclase of rutabaga, a Drosophila learning mutant
23. 2+/calmodulin-responsive adenylyl cyclase
24. Differential expression of type I, II, and V adenylyl cyclase gene in the postnatal developing rat brain
25. Impaired cerebellar long-term potentiation in type I adenylyl cyclase mutant mice
26. Developmentally expressed Ca(2+)-sensitive adenylyl cyclase activity is disrupted in the brains of type I adenylyl cyclase mutant mice
27. Altered sensory processing in the somatosensory cortex of the mouse mutant barrelless
28. Loss of adenylyl cyclase I activity disrupts patterning of mouse somatosensory cortex
29. Calcium-stimulated adenylyl cyclase activity is critical for hippocampus-dependent long-term memory and late phase LTP
30. Differential regulation of Ca(2+)-calmodulin stimulated and Ca(2+)-insensitive adenylyl cyclase messenger RNA in intact and denerrated mouse hippocampus
31. Calcium control of adenylyl cyclase: The calcineurin connection
32. Gαs-induced neurodegeneration in Caenorhabditis elegans
33. G protein hyperactivation of the Caenorhabditis elegans adenylyl cyclase SGS-1 induces neuronal degeneration
34. Calcineurin regulated adenylyl cyclase in the brain
35. Involvement of a calcineurin/inhibitor-1 phosphatase cascade in hippocampal long-term depression
36. FK506, a Ca2+/calmodulin-dependent phosphatase inhibitor, inhibits the induction of long-term potentiation in the rat hippocampus
37. Inhibition of adenylate cyclase by Ca(2+) - A counterpart to stimulation by Ca2+/calmodulin
38. Inhibition by calcium of mammalian adenylyl cyclases
39. Isolation and characterization of a novel cardiac adenylyl cyclase cDNA
40. Cloning and characterization of a sixth adenylyl cyclase isoform: Types V and VI constitute a subgroup within the mammalian adenylyl cyclase family
41. Two members of a widely expressed subfamily of hormone-stimulated adenylyl cyclases
42. Cloning and expression of an adenylyl cyclase localized to the corpus striatum
43. Capacitative calcium entry
44. 2+ inhibitable adenylyl cyclase from NCB-20 cells
45. Capacitative Ca2+ entry regulates Ca(2+)-sensitive adenylyl cyclases
46. Calcium entry via L-type calcium channels acts as a negative regulator of adenylyl cyclase activity and cyclic AMP levels in cardiac myocytes
47. 2+-sensitive adenylyl cyclases
48. Adenylyl cyclases and the interaction between calcium and cAMP signalling
49. Functional co-localization of transfected Ca(2+)-stimulable adenylyl cyclases with capacitative Ca2+ entry sites
50. Identification and subcellular localization of the subunits of L-type calcium channels and adenylyl cyclase in cardiac myocytes
51. Inhibition of adenylyl cyclase isoforms V and VI by various Gβγ subunits
52. Regulation of adenylyl cyclase by protein kinase A
53. Lowered responsiveness of the catalyst of adenylyl cyclase to stimulation by Gs in heterologous desensitization: A role for adenosine 3′,5′-monophosphate-dependent phosphorylation
54. Adenylyl cyclase 6 is selectively regulated by protein kinase A phosphorylation in a region involved in Gαs stimulation
55. Regulation of type V adenylyl cyclase by PMA-sensitive and -insensitive protein kinase C isoenzymes in intact cells
56. Inhibition of cloned adenylyl cyclases by mutant-activated Gi-α and specific suppression of type 2 adenylyl cyclase inhibition by phorbol ester treatment
57. Stimulation of specific types of Gs-stimulated adenylyl cyclases by phorbol ester treatment
58. Type-specific stimulation of adenylylcyclase by protein kinase C
59. Protein kinase C inhibits adenylyl cyclase type VI activity during desensitization of the A2a-adenosine receptor-mediated cAMP response
60. The N terminus domain of type VI adenylyl cyclase mediates its inhibition by protein kinase C
61. Specific activation of adenylyl cyclase V by a purinergic agonist
62. Expression of type V adenylyl cyclase is required for epidermal growth factor-mediated stimulation of cAMP accumulation
63. Selective inhibition of adenylyl cyclase type V by the dopamine D3 receptor
64. Multiplicity in type V adenylylcyclase: Type V-a and type V-b
65. Type V, but not type VI adenylyl cyclase mRNA accumulates in the heart during ontogenic development: Correlation with adenylyl cyclase activity
66. Changes in type VI adenylyl cyclase isoform expression correlate with a decreased capacity for cAMP generation in the aging ventricle
67. Determination and cellular localisation of adenylyl cyclase isoenzymes expressed in embryonic chick heart
68. Adenylyl cyclase and G protein receptor kinase expression during development of heart failure
69. Adenylylcyclase increases responsiveness to catecholamine stimulation in transgenic mice
70. Cardiac-directed adenylyl cyclase expression improves heart function in murine cardiomyopathy
71. Expression of adenylyl cyclase mRNAs in the adult, in developing, and in the Brattleboro rat kidney
72. Localization of mRNAs encoding Ca2+-inhibitable adenylyl cyclases along the renal tubule: Functional consequences for regulation of the cAMP content
73. Functional properties of Ca2+inhibitable type 5 and type 6 adenylyl cyclases and role of Ca2+ increase in the inhibition of intracellular cAMP content
74. Decreased renal Na-K-2Cl cotransporter abundance in mice with heterozygous disruption of the Gsα gene
75. The cyclic AMP-mediated stimulation of cell proliferation
76. Suppression of Ras-induced transformation of NIH 3T3 cells by activated Gαs
77. Identity of adenylyl cyclase isoform determines the rate of cell cycle progression in NIH 3T3 cells
78. Different expression of adenylyl cyclase isoforms after retinoic acid induction of P19 teratocarcinoma cells
79. Adenylyl cyclase activity and gene expression during mesodermal differentiation of the P19 embryonal carcinoma cells
80. Expression of adenylyl cyclase mRNAs in the denervated and in the developing mouse skeletal muscle
81. Regulation of type II adenylyl cyclase mRNA in rabbit skeletal muscle by chronic motor nerve pacing
82. Beta-adrenergic stimulation of brown adipocyte proliferation
83. Expression of adenylyl cyclase subtypes in brown adipose tissue: Neural regulation of type III
84. Perinatal expression of adenylyl cyclase subtypes in rat brown adipose tissue
85. Severe impairment of spermatogenesis in mice lacking the CREM gene
86. Spermiogenesis deficiency and germ-cell apoptosis in CREM-mutant mice
87. Multiple forms of adenylate cyclase
88. Cytosolic adenylyl cyclase defines a unique signaling molecule in mammals
89. Specific expression of soluble adenylyl cyclase in male germ cells
90. Identification of a specialized adenylyl cyclase that may mediate odorant detection
91. The type III calcium/calmodulin-sensitive adenylyl cyclase is not specific to olfactory sensory neurons
92. The olfactory adenylyl cyclase III is expressed in rat germ cells during spermiogenesis
93. Golf: An olfactory neuron specific-G protein involved in odorant signal transduction
94. Ultrastructural localization of olfactory transduction components: The G protein subunit Golf alpha and type III adenylyl cyclase
95. Genes encoding components of the olfactory signal transduction cascade contain a DNA binding site that may direct neuronal expression
96. Expression of members of the putative olfactory receptor gene family in mammalian germ cells
97. Olfactory receptors are displayed on dog mature sperm cells
98. Odorant receptors and desensitization proteins colocalize in mammalian sperm
99. Developmental regulation of unique adenosine 3′-5′-monophosphate-specific phosphodiesterase variants during rat spermatogenesis
100. Specific repertoire of olfactory receptor genes in the male germ cells of several mammalian species
101. The olfactory adenylyl cyclase type 3 is expressed in male germ cells
102. Molecular mechanisms of drug addiction
103. Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance
104. Reduction of morphine abstinence in mice with a mutation in the gene encoding CREB
105. Acute and chronic opiate-regulation of adenylate cyclase in brain: Specific effects in locus coeruleus
106. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene
107. A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function
108. Chronic morphine administration causes region-specific increase of brain type VIII adenylyl cyclase mRNA
109. Acute and chronic activation of the mu-opioid receptor with the endogenous ligand endomorphin differentially regulates adenylyl cyclase isozymes
110. Kappa-Opioid receptor-transfected cell lines: Modulation of adenylyl cyclase activity following acute and chronic opioid treatments
111. Sensitization of the adenylyl cyclase system in cloned kappa-opioid receptor-transfected cells following sustained agonist treatment: A chimeric study using G protein αi2/αq subunits
112. Induction of multiple effects on adenylyl cyclase regulation by chronic activation of the human A3 adenosine receptor
113. Adenylate cyclase supersensitivity: A general means of cellular adaptation to inhibitory agonists?
114. Adenylyl cyclase supersensitization in μopioid receptor-transfected Chinese hamster ovary cells following chronic opioid treatment
115. Chronic opioid treatment induces adenylyl cyclase V super-activation: Involvement of Gβγ
116. Chronic morphine augments G(β)(γ)/Gs(α) stimulation of adenylyl cyclase: Relevance to opioid tolerance
117. Isoform-specific sensitization of adenylyl cyclase activity by prior activation of inhibitory receptors: Role of beta gamma subunits in transducing enhanced activity of the type VI isoform
118. μ-Opioid receptors inhibit dopamine-stimulated activity of type V adenylyl cyclase but enhance dopamine-stimulated activity of type VII adenylyl cyclase
119. Opiate-induced adenylyl cyclase superactivation is isozyme-specific
120. Bimodal opioid regulation of cyclic AMP formation: Implications for positive and negative coupling of opiate receptors to adenylyl cyclase
121. Behavioural and biochemical evidence for signs of abstinence in mice chronically treated with delta-9-tetrahydrocannabinol
122. Cannabinoid withdrawal is dependent upon PKA activation in the cerebellum
123. Differential superactivation of adenylyl cyclase isozymes after chronic activation of the CB(1) cannabinoid receptor
124. Ethanol's effects on cortical adenylate cyclase activity
125. Chronic ethanol exposure of PC 12 cells alters adenylate cyclase activity and intracellular cyclic AMP content
126. Adenylyl cyclases and alcohol
127. Selective activation by short chain alcohols of glucagon responsive adenyl cyclase in liver
128. Effects of ethanol on calmodulin levels in mouse striatum and cerebral cortex
129. Effect of ethanol on mouse cerebral conical β-adrenergic receptors
130. Effects of ethanol in vitro on the β adrenergic receptor-coupled adenylate cyclase system
131. Selective effects of ethanol on the generation of cAMP by particular members of the adenylyl cyclase family
132. Differences in platelet enzyme activity between alcoholics and nonalcoholics
133. Adenosine is required for ethanol-induced heterologous desensitization
134. Activation of protein kinase A is necessary but not sufficient for ethanol-induced desensitization of cyclic AMP production
135. Adenosine receptors mediate cellular adaptation to ethanol in NG108-115 cells
136. Quantitative changes in G proteins do not mediate ethanol-induced downregulation of adenylyl cyclase in mouse cerebral cortex
137. Ethanol's actions on cAMP-mediated signaling in cells transfected with type VII adenylyl cyclase
138. Ethanol potentiates adenylyl cyclase via direct phosphorylation mediated by PKCd
139. Ethanol exposure alters the phosphorylation of cyclic AMP responsive element binding protein and cyclic AMP responsive element binding activity in rat cerebellum
140. Role of extracellular adenosine in ethanol-induced desensitization of cyclic AMP production
141. Chronic ethanol administration decreases phosphorylation of cyclic AMP response element-binding protein in granule cells of rat cerebellum
142. Ethanol causes translocation of cAMP-dependent protein kinase catalytic subunit to the nucleus
143. Ethanol intoxication in Drosophila: Genetic and pharmacological evidence for regulation by the cAMP signaling pathway
144. Ethanol consumption and resistance are inversely related to neuropeptide Y levels
145. Platelet adenylyl cyclase activity in alcoholics and subtypes of alcoholics: WHO/ISBRA study clinical centers
146. An initial study of the relationship between platelet adenylyl cyclase activity and alcohol use disorder criteria
147. Platelet adenylyl cyclase activity as a biochemical trait marker for predisposition to alcoholism
148. Immunological assessment of the distribution of type VII adenylyl cyclase in brain
149. Generation of transgenic mice that overexpress type 7 adenylyl cyclase and the response of these mice to ethanol
150. Cyclic AMP signaling in ethanol sensitivity and tolerance
151. Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas
152. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas
153. Adenylyl cyclases: Structure, regulation and function in an enzyme superfamily
154. New form of pseudohypoparathyroidism with abnormal catalytic adenylate cyclase
155. Retinal-specific guanylate cyclase gene mutations in Leber's congenital amanrosis
156. Mutations in the promoter of adenylyl cyclase (AC)-III gene, overexpression of AC-III mRNA, and enhanced cAMP generation in islets from the spontaneously diabetic GK rat model of type 2 diabetes
157. Altering the receptor-effector ratio by transgenic overexpression of type V adenylyl cyclase: Enhanced basal catalytic activity and function without increased cardiomyocyte beta-adrenergic signalling
158. Enhanced cardiac function in transgenic mice expressing a Ca(2+)-stimulated adenylyl cyclase
159. Transgenic replacement of type V adenylyl cyclase identifies a critical mechanism of beta-adrenergic receptor dysfunction in the Gαq overexpressing mouse
160. Sensitivity to morphine analgesia is increased in transgenic mice overexpressing adenylyl cyclase type VII in their CNS
161. Crystal structure of the catalytic domains of adenylyl cyclase in a complex with Gsα.GTP γS
162. Catalytic mechanism of the adenylyl and guanylyl cyclases: Modeling and mutational analysis
163. Structure of the adenylyl cyclase catalytic core
164. Conversion of forskolin-insensitive to forskolin-sensitive (mouse-type IX) adenylyl cyclase
165. The interactions of adenylate cyclases with P-site inhibitors
166. 2′,5′-dideoxyadenosine 3′-polyphosphates are potent inhibitors of adenylyl cyclases
167. Inhibition of adenylyl cyclase by a family of newly synthesized adenine nucleoside 3′-polyphosphates
168. Adenine nucleoside 3′-tetraphosphates are novel and potent inhibitors of adenylyl cyclases
169. 32p] 3′-ATP and the mechanism for P-site-mediated inhibition
170. Isozyme-dependent sensitivity of adenylyl cyclases to P-site-mediated inhibition by adenine nucleosides and nucleoside 3′-polyphosphates
171. Adenylyl cyclase P-site ligands accelerate differentiation in Ob1771 preadipocytes
172. Inhibition of adenylyl cyclase by acyclic nucleoside phosphonate antiviral agents
173. Domoic acid inhibits adenylate cyclase activity in rat brain membranes
174. Inhibition of adenylate cyclase in perfusion mouse palate by secalonic acid D
175. Differential effects of ceramides upon adenylyl cyclase subtypes
176. Ceramide selectively inhibits calcium-mediated potentiation of β-adrenergic-stimulated cyclic nucleotide accumulation in rat pinealocytes
177. Isolation and characterization of 9-hydroxy-10-trans, 12-cis-octadecadienoic acid, a novel regulator of platelet adenylate cyclase from Glechoma hederacea L
178. Inhibition of adenylyl cyclases by 12(S)-hydroxyeicosatetraenoic acid
179. Actions of lithium on second messenger activity in the brain: The adenylate cyclase and phosphoinositide systems
180. Effects of minocycline on accumulation of cyclic AMP in cerebral cortex of rat: A comparison with lithium
181. Riboflavin: Inhibitory effects on receptors, G-proteins and adenylyl cyclase
182. Selective inhibition of adenylate cyclase in bovine cortex by quinones: A novel cellular substrate for quinone cytotoxicity
183. Glycerophosphoinositol 4-phosphate, a putative endogenous inhibitor of adenylylcyclase
184. Stoichiometry of receptor-Gs-adenylate cyclase interaction
185. Quantification of signalling components and amplification in the β-adrenergic-receptor-adenylate cyclase pathway in isolated adult rat ventricular myocytes
186. Agonist regulation of adenylate cyclase activity in neuroblastoma x glioma hybrid NG108-15 cells transfected to coexpress adenylate cyclase type II and the beta 2-adrenoceptor. Evidence that adenylate cyclase is the limiting component for receptor-mediated stimulation of adenylate cyclase activity
187. Increased expression of adenylylcyclase type VI proportionately increases beta-adrenergic receptor-stimulated production of cAMP in neonatal rat cardiac myocytes
188. Selective enhancement of beta-adrenergic receptor signaling by overexpression of adenylyl cyclase type 6: Colocalization of receptor and adenylyl cyclase in caveolae of cardiac myocytes
189. Inhibition of adenylyl cyclase by caveolin peptides
190. Compartmentation of cyclic adenosine 3′,5′- monophosphate signaling in caveolae
191. Organization of G proteins and adenylyl cyclase at the plasma membrane
192. Activated cardiac adenosine A(1) receptors translocate out of caveolae
193. The structure of adenylate cyclase systems
194. Octyl glucoside extracts GTP-binding regulatory proteins from rat brain "synaptoneurosomes" as large, polydisperse structures devoid of beta gamma complexes and sensitive to disaggregation by guanine nucleotides
195. Catalytic mechanism and regulation of mammalian adenylyl cyclases
196. Role of cytoskeletal organization in the regulation of adenylate cyclase-cyclic adenosine monophosphate by hormones
197. Participation of tubulin in the stimulatory regulation of adenylyl cyclase in rat cerebral cortex membranes
198. Tubulin stimulates adenylyl cyclase activity in rat striatal membranes via transfer of guanine nucleotide to Gs protein
199. Direct stimulation of adenylate cyclase by mechanical forces in S49 mouse lymphoma cells during hyposmotic swelling
200. Quantitative autoradiography of [3H]forskolin binding sites in postmortem brain staged for Alzheimer's disease neurofibrillary changes and amyloid deposits
201. Cyclic AMP
202. Adenylyl cyclase, a coincidence detector for nitric oxide
203. The role of Ca2+/calmodulin-stimulable adenylyl cyclases as molecular coincidence detectors in memory formation
204. Type I adenylyl cyclase functions as a coincidence detector for control of cyclic AMP response element-mediated transcription: Synergistic regulation of transcription by Ca2+ and isoproterenol
205. Gating by cyclic AMP: Expanded role for an old signaling pathway
206. Diurnal variation of the adenylyl cyclase type 1 in the rat pineal gland
207. Molecular clocks
208. Pregnancy-related modifications of rat myometrial Gs proteins: ADP ribosylation, immunoreactivity and gene expression studies
209. Down-regulation of Gαs in human myometrium in term and preterm labor: A mechanism of parturition
210. G protein signalling pathways in myomethrium: Affecting the balance between contraction and relaxation
211. Regulation of myometrial Gi2, Gi3, and Gq expression during pregnancy. Effects of progesterone and estradiol
212. Involvement of protein kinase A in the regulation of intracellular free calcium and phosphoinositide turnover in rat myometrium
213. A role for AKAP (A kinase anchoring protein) scaffolding in the loss of a cyclic adenosine 3′,5′-monophosphate inhibitory response in late pregnant rat myometrium